This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
milla1cf Wed, 02/07/2024 - 18:05 February 7, 2024 — The Consumer Technology Association ( CTA ) and the American College of Cardiology ( ACC ) are announcing the release of their second industry framework for the use of consumer cardiovasculartechnology solutions in the screening and diagnosis for cardiovascular conditions.
The new scientific statement, “Use of Artificial Intelligence in Improving Outcomes in Heart Disease,” comes amid intense attention on AI as a way to improve cardiovasculardisease prevention, detection, diagnosis and treatment. to ensure safety and effectiveness to mitigate harm as technologies rapidly evolve.
However, conversations are ongoing around bestpractices and standards of care regarding contrast management and treatment for those with higher risk factors, like compromised renal function. About ACIST Physicians worldwide rely on our diagnostic technologies to give them the power to visualize, assess and inform patient treatment.
The collaboration seeks to provide access to emerging technologies, like Medis QFR, while also reducing complexity in the cath lab to improve the operating environment for clinicians.
The workbook, according to the Washington, DC-based organization, also aims to help clinical practices determine whether they are ready for RPM utilization and provide considerations about how to set up an RPM program. However, it noted, guidance is needed on the optimal use of direct-to-consumer devices as a care tool. “As
In a room of 20 people, it’s likely that about 10 of them, or half, will presently have some form of cardiovasculardisease (CVD). CVD is among the most prevalent diseases in the U.S., This includes artificial intelligence (AI), remote monitoring, virtual care, and other emerging technological advancements.
However, conversations are ongoing around bestpractices and standards of care regarding contrast management and treatment for those with higher risk factors, like compromised renal function. About ACIST Physicians worldwide rely on our diagnostic technologies to give them the power to visualize, assess and inform patient treatment.
Electronic Health Record (EHR) software has an essential technology tool for cardiology clinics in meeting the ever-changing demands of the healthcare industry. The reporting features found in a comprehensive cardiology EHR platform can truly improve workflow and increase practice efficiency.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content